- Trials with a EudraCT protocol (76)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
76 result(s) found for: Dental surgery.
Displaying page 1 of 4.
EudraCT Number: 2005-000869-20 | Sponsor Protocol Number: DC0071-BB-404-8B | Start Date*: 2005-08-08 |
Sponsor Name:Pierre Fabre Médicament | ||
Full Title: Post-operative care by chlorhexidine mouthwash after periodontal surgery. Randomised, parallel groups; blind study, DC071BB versus placebo, in patients presenting with periodontal surgery with sutu... | ||
Medical condition: Post-operative care for patients having periodontal surgery with gingival suture. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) EE (Completed) LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002168-42 | Sponsor Protocol Number: 20052017 | Start Date*: 2018-12-18 |
Sponsor Name:Iciar Arteagoitia Calvo | ||
Full Title: Efficacy of clindamycin in preventing infection and failure after dental implant placement: a placebo-controlled randomized clinical trial. | ||
Medical condition: Healthy volunteers (Postoperative infections and dental implant failures) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003258-21 | Sponsor Protocol Number: PDC-01-0205 | Start Date*: 2022-05-19 | |||||||||||
Sponsor Name:Cessatech A/S | |||||||||||||
Full Title: Analgesic Efficacy and Pharmacokinetic-pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 after Impacted Mandibular Third Molar Extraction | |||||||||||||
Medical condition: Healthy male or female participants scheduled for surgical removal of an impacted mandibular third molar, where bone removal is judged to be needed. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002243-17 | Sponsor Protocol Number: DEXCOM | Start Date*: 2014-10-24 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Conscious sedation for procedures in Dental and Minor Maxillofacial Surgery Unit: optimization of the dexmedetomidine dose (Dexdor®). | |||||||||||||
Medical condition: Sedation for procedures in Dental and Minor Maxillofacial Surgery Unit | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006617-32 | Sponsor Protocol Number: 06/Q0605/1 | Start Date*: 2007-05-02 |
Sponsor Name:Kings College Hospital Trust R&D | ||
Full Title: A prospective randomised double blind parallel trial comparing Articaine versus Lignocaine for mandibular dentistry | ||
Medical condition: necessary dental surgery | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2013-000024-34 | Sponsor Protocol Number: CH-MAX-FACC-TR-12 | Start Date*: 2015-01-13 | |||||||||||
Sponsor Name:AOU di Bologna, Policlinico S.Orsola-Malpighi | |||||||||||||
Full Title: Use of PRP from umbilical cord in post-extractive sites | |||||||||||||
Medical condition: • Patients who require extraction of dental elements and subsequent implant rehabilitation in the same site. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003551-20 | Sponsor Protocol Number: 2006-MSC-01 | Start Date*: 2007-06-25 |
Sponsor Name:Department of Oral Surgery Dental School Med. Univ. Graz, Austria | ||
Full Title: The Effect of adult MSC on Bone Regeneration and Osseointegration of Dental Implants following a Sinus Augmentation Procedure | ||
Medical condition: In patients with biltareral edentulous areas and resorbed alveolar processes in the maxilla a bilateral sinus augmentation with Bio-OssTM, CE certified (Geistlich Biomaterials, Wolhusen Switzerlan... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004564-26 | Sponsor Protocol Number: BAS20 | Start Date*: 2021-09-20 | |||||||||||
Sponsor Name:Karolinska Institute | |||||||||||||
Full Title: Role of antibiotics in conjunction with oral bone augmentation procedures (BAS20) | |||||||||||||
Medical condition: Patients requiring bone augmentation procedure prior to, or in conjunction to installation of dental implants. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000535-86 | Sponsor Protocol Number: HAP.2011-002 | Start Date*: 2011-03-29 | |||||||||||
Sponsor Name:CHU AMBROISE PARE | |||||||||||||
Full Title: A PHASE IIb STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ROPIVACAINE COMPARED TO ADRENALINE-LIDOCAINE TO REDUCE PAIN IN PATIENT UNDERGOING SURGERY FOR THIRD MOLAR TEETH EXTRACTION. | |||||||||||||
Medical condition: third molar theeth included needing surgical extraction | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005478-66 | Sponsor Protocol Number: PDY5808 | Start Date*: 2006-02-09 | |||||||||||
Sponsor Name:Sanofi-Synthelabo Recherche | |||||||||||||
Full Title: Effect of a single oral 120 µg dose of SSR150106XB compared to placebo on the assessment of post dental surgical pain after extraction of an impacted or partially impacted third molar in 90 male an... | |||||||||||||
Medical condition: Men and women who are to undergo elective surgery for extraction of at least one lower impacted or partially impacted third molar | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004046-41 | Sponsor Protocol Number: 273551 | Start Date*: 2021-12-09 |
Sponsor Name:University of Bergen, | ||
Full Title: A multicentre clinical trial; Alveolar bone augmentation using Mesenchymal Stem Cells and biphasic calcium phosphate granules prior to dental implants | ||
Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011980-35 | Sponsor Protocol Number: 09PUK/DCsc05 | Start Date*: 2009-08-03 | |||||||||||
Sponsor Name:IBSA Institut Biochimique SA | |||||||||||||
Full Title: Multicentre, randomised, double-blind (double-dummy), active comparator-controlled, phase III study of the efficacy and safety of a single s.c. Diclofenac HPBCD 75mg/1ml injection as compared to a ... | |||||||||||||
Medical condition: acute moderate-to-severe post-surgical pain from dental surgery (impacted 3rd molar extraction) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2009-011663-37 | Sponsor Protocol Number: 09PUK/DCsc04 | Start Date*: 2009-07-28 | |||||||||||
Sponsor Name:IBSA, Institut Biochimique SA | |||||||||||||
Full Title: Multicentre, randomized, double-blind, active comparator-and placebo-controlled, parallel-group phase III clinical study for the evaluation of Diclofenac HPBCD 25, 50 mg/ml administered as a single... | |||||||||||||
Medical condition: acute moderate-to-severe post-surgical pain from dental surgery (impacted 3rd molar extraction) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2014-005269-66 | Sponsor Protocol Number: BAYH6689/13130 | Start Date*: 2015-02-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of an Extended Release Naproxen Sodium Tablet in Postsurgical Den... | |||||||||||||
Medical condition: Toothache | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-005049-67 | Sponsor Protocol Number: 19762 | Start Date*: 2018-08-29 | |||||||||||
Sponsor Name:Bayer HealthCare LLC | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Trial to Compare the Duration of Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Ibuprofen Tablets in Postsurgical Dental Pain | |||||||||||||
Medical condition: Pain relief | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004481-16 | Sponsor Protocol Number: VRA105345 | Start Date*: 2005-12-19 |
Sponsor Name:GlaxoSmithKline Research and Development | ||
Full Title: A multi-centre, randomised, single blind, placebo controlled, parallel group study to examine the effect of single doses of SB-705498, a TRPV1 receptor antagonist, on pain following third molar too... | ||
Medical condition: Dental pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002691-18 | Sponsor Protocol Number: CBA106809 | Start Date*: 2006-10-03 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development | |||||||||||||
Full Title: A multi-centre, randomised, single-blind, placebo-controlled, parallel group study to investigate the efficacy of single pre-emptive doses of GW842166X, a non-cannabinoid CB2 receptor agonist, on p... | |||||||||||||
Medical condition: Inflammatory Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) IT (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002571-40 | Sponsor Protocol Number: 231006 | Start Date*: 2007-05-18 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A randomized, double-blind, active and placebo controlled trial to compare the relative analgesic efficacy and safety of a single intravenous dose of Org 28611 3.0 µg/kg, morphine sulfate 0.12 mg/... | |||||||||||||
Medical condition: Postoperative analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001227-39 | Sponsor Protocol Number: 779322 | Start Date*: 2019-12-11 | |||||||||||
Sponsor Name:University of Bergen, Faculty of Medicin, Department of Clinical Dentistry | |||||||||||||
Full Title: A randomized controlled clinical trial to assess the efficacy of a combination of autologous mesenchymal stem cells and biomaterial in jaw bone regeneration prior to dental implant placement in com... | |||||||||||||
Medical condition: Patients in need of dental implant(s) in the upper and lower jaws with presence of bone defects with loss in vertical height and < than 4 mm in lateral width | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) NO (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001412-30 | Sponsor Protocol Number: FMLD-FEBETRADI-PILOT-43_FIII | Start Date*: 2018-07-13 | |||||||||||
Sponsor Name:Laboratorios Farmalíder S.A. | |||||||||||||
Full Title: Double blind, randomized, pilot clinical trial controlled with placebo to evaluate the comparative efficacy of ibuprofen combined with different doses of tramadol and tramadol 100 mg by intravenous... | |||||||||||||
Medical condition: Moderate-Intense pain in Dental Surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
